Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03168659 · ClinicalTrials.gov registry record · NA

CardioFocus HeartLight Post-Approval Study

A NA study of Atrial Fibrillation, sponsored by CardioFocus.

Recruiting
Registry status
NA
Development phase
250
Enrollment target
4
Study locations

NCT03168659 is a NA study of Atrial Fibrillation that is actively recruiting participants, run by CardioFocus. The registered enrollment target is 250 participants, below the 2,996-participant average among 202 other Atrial Fibrillation trials with a reported enrollment target (92% lower). The trial reports 4 study locations across 4 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03168659, a NA study of Atrial Fibrillation, is actively recruiting participants, sponsored by CardioFocus.

RECRUITING
Registry status
NA
Development phase
250 participants
Enrollment target
4
Study locations

Study Summary

This is a post-approval study to evaluate the clinical outcomes in a cohort of participants treated during commercial use of the HeartLight System to confirm results of the previously conducted pivotal clinical study.

Conditions Studied

Interventions

  • PROCEDURE Ablation
  • DEVICE HeartLight

Study Locations (4)

Arizona

  • University of Arizona Sarver HeartCenter - Tucson

Illinois

  • University of Illinois - Chicago

New York

  • Mount Sinai Hospital - New York

Virginia

  • University Of Virginia Health System - Charlottesville

Trial Details

FieldValue
Enrollment Target 250 participants
Start Date 2017-06-16
Est. Completion 2028-10
Phase NA

Sponsor

CardioFocus

4 total trials

What the Registry Record Tells You About NCT03168659

The ClinicalTrials.gov registry entry for NCT03168659 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 250 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,996-participant average among 202 other Atrial Fibrillation trials with a reported enrollment target (92% lower). The listed sponsor is CardioFocus, which has 4 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Atrial Fibrillation appearing as the primary indexed condition, and to 2 interventions - of which Ablation is the first listed.

NCT03168659 reports 4 study locations spanning 4 distinct geographic areas - top geographies include Arizona, Illinois, New York.

Frequently Asked Questions

What is clinical trial NCT03168659 about?

NCT03168659 is a clinical study titled "CardioFocus HeartLight Post-Approval Study". This is a post-approval study to evaluate the clinical outcomes in a cohort of participants treated during commercial use of the HeartLight System to confirm results of the previously conducted pivotal clinical study.

What is the current status of trial NCT03168659?

This trial is currently recruiting. It is a NA study. The enrollment target is 250 participants. The study started on 2017-06-16. Estimated completion is 2028-10.

What conditions does trial NCT03168659 study?

This clinical trial studies the following conditions: Atrial Fibrillation.

What interventions are being tested in trial NCT03168659?

The interventions under investigation include: Ablation (PROCEDURE), HeartLight (DEVICE).

Who is sponsoring clinical trial NCT03168659?

This trial is sponsored by CardioFocus, which has 4 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03168659 being conducted?

This trial has 4 study locations across Arizona, Illinois, New York, Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Atrial Fibrillation

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.